Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HEMO-ALERT

K-Number: K893830 · 1989-10-12

Decision Date1989-10-12
Product CodeDQO
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

HEMO-ALERT is the device name listed in this FDA 510(k) record. The listed applicant is Koregon Enterprise, Inc.. It received FDA 510(k) clearance on 1989-10-12 under 510(k) number K893830. The device is classified under product code DQO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HEMO-ALERT?

HEMO-ALERT is a medical device that received FDA 510(k) clearance on 1989-10-12. The listed applicant is Koregon Enterprise, Inc.. The 510(k) number is K893830.

When did HEMO-ALERT receive FDA 510(k) clearance?

HEMO-ALERT received FDA 510(k) clearance on 1989-10-12, under 510(k) number K893830.

Who is the listed applicant for HEMO-ALERT?

The FDA 510(k) record lists Koregon Enterprise, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HEMO-ALERT?

The FDA product code for HEMO-ALERT is DQO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DQO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑